Navidea Biopharmaceuticals, Inc.
USD0.00
-0.00 (-0.00%)
CEO
Craig A. Dais CPA
IPO Date
1992-11-10
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Open
$0.00
Prev. Close
$0.00
Day Low
$0.00
Day High
$0.00
52W Low
$0.00
52W High
$0.04
Market Cap
$0.00B
Volume
0.00M
| -2.5 |
| 31 Dec 2020 | FY | 99.9% | -1171.8% | -815.0% | -138.2% | 1.02 | 1.38 | -4.8 |
| 31 Dec 2019 | FY | 75.0% | -41120.9% | 678.9% | -263.7% | -0.66 | 0.76 | -1.7 |
| 31 Dec 2018 | FY | 70.0% | -5000.1% | -925.7% | -230.1% | 0.18 | 1.66 | -1.1 |
| 31 Dec 2017 | FY | 99.8% | 4139.7% | 658.6% | 360.6% | 0.21 | 1.71 | 0.8 |
| 31 Dec 2016 | FY | 88.7% | -287.8% | 21.0% | -114.8% | -0.90 | 0.15 | -6.9 |
| 31 Dec 2015 | FY | 86.8% | -208.0% | 50.8% | -184.2% | -1.12 | 2.03 | -7.3 |
| 31 Dec 2014 | FY | 66.9% | -569.4% | 119.9% | -299.7% | -1.14 | 0.95 | -7.9 |
| 31 Dec 2013 | FY | 70.6% | -3776.6% | 1064.9% | -105.9% | -6.90 | 3.31 | -5.9 |
| 0.2 |
| 31 Mar 2023 | Q1 | 0.0% | 0.0% | 15.0% | -62.4% | -0.24 | 0.13 | -1.4 |
| 31 Dec 2022 | Q4 | -8102.6% | -570922.8% | 41.3% | -79.7% | -0.29 | 0.32 | -0.5 |
| 30 Sept 2022 | Q3 | -1688.7% | -75942.3% | 115.1% | -91.2% | -0.37 | 0.60 | -0.3 |
| 30 Jun 2022 | Q2 | 92.7% | -46011.0% | 66.2% | -119.8% | -0.19 | 0.22 | -1.8 |
| 31 Mar 2022 | Q1 | -104.4% | -5872.1% | 124.7% | -83.2% | -0.13 | 0.47 | -2.0 |
| 31 Dec 2021 | Q4 | -2.7% | -7253.8% | 3427.5% | -55.0% | -7.03 | 1.02 | -2.1 |
| 30 Sept 2021 | Q3 | 49.6% | -2529.3% | -71.6% | -27.2% | 0.11 | 1.87 | -5.4 |
| 30 Jun 2021 | Q2 | 100.0% | -1024.4% | -46.9% | -23.7% | 0.08 | 2.50 | -5.0 |